Has Rachel Call received payments from drug or device companies?

Yes. Drug and device makers reported $1,879 in general payments to Rachel Call across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachel Call did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachel Call come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachel Call

Physician Assistant · Spokane, WANPI 1265035166

Payments from drug & device makers

$1,879in general payments, 2019–2025

Across 85 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$302
Novartis$190
CSL Behring$183
Sanofi$170
Pharming Healthcare, Inc.$147
Organon$140
plus $749 from 14 others

What the payments were for

Consulting fees$261%
Food & beverage$1,85399%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	15	$302
Novartis	15	$190
CSL Behring	10	$183
Sanofi	8	$170
Pharming Healthcare, Inc.	6	$147
Organon	2	$140
GSK	5	$109
Takeda Pharmaceuticals U.S.A., Inc.	3	$87
Regeneron Healthcare Solutions, Inc.	3	$79
Blueprint Medicines Corporation	2	$73
ARS Pharmaceuticals Operations, Inc.	3	$69
Incyte Corporation	3	$53
Genentech USA, Inc.	2	$46
Amgen	2	$41
Tersera Therapeutics LLC	1	$39
LEO Pharma Inc.	1	$37
Biocryst US Sales Co., LLC	1	$33
Lilly USA, LLC	1	$32
ADMA Biomanufacturing LLC	1	$26
Octapharma USA, Inc.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NEXPLANON$132

How this compares

$1,879 in reported general payments places this provider in the 85th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	21	$19,135
JanuviaSitagliptin Phosphate	18	$18,149
OzempicSemaglutide	17	$15,315
JardianceEmpagliflozin	17	$14,304
Rosuvastatin Calcium	30	$2,430
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	19	$1,803
Albuterol Sulfate HfaAlbuterol Sulfate	25	$774
Lisinopril	90	$761
Amlodipine Besylate	56	$668
Atorvastatin Calcium	54	$600
Omeprazole	39	$426
Potassium Chloride	17	$384
Levothyroxine Sodium	45	$373
Metoprolol Succinate	37	$324
Mirtazapine	13	$321

Paid to pharmacies, not to this prescriber.

Other physician assistant in Spokane

Regan BrownSpokane$56K
Makena TurnerSpokane$20K
Jeremy BrettSpokane$18K
John WhiteSpokane$13K
Staci DumertonSpokane$12K
Daniel RhoadsSpokane$9K
Lori TschetterSpokane$9K
Jacob WolffSpokane$8K
Trent LenglSpokane$7K
Gareth OlstadSpokane$7K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →